Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients-Reference-Cited by-同舟云学术

Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients

Published:2011-11-18 Issue:1 Volume:55 Page:199-208
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Myers Robert P.,Pomier-Layrargues Gilles,Kirsch Richard,Pollett Aaron,Duarte-Rojo Andres,Wong David,Beaton Melanie,Levstik Mark,Crotty Pam,Elkashab Magdy

Publisher

Wiley

Subject

Hepatology

Reference28 articles.

1. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis;Sandrin;Ultrasound Med Biol,2003

2. Non-invasive evaluation of liver fibrosis using transient elastography;Castera;J Hepatol,2008

3. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C;Ziol;HEPATOLOGY,2005

4. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C;Castera;Gastroenterology,2005

5. Transient elastography for the noninvasive assessment of liver fibrosis: a multicentre Canadian study;Myers;Can J Gastroenterol,2010

Cited by 434 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements of non‐invasive imaging technologies for the diagnosis and staging of liver fibrosis: Present and future;VIEW;2024-07-15

2. A Comparative Study of Novel Fibrosis Index and Other Non-invasive Serum Indices for Predicting Fibrosis in Patients of Chronic Liver Disease;Cureus;2024-07-02

3. Diagnosis and non‐invasive assessment of MASLD in type 2 diabetes and obesity;Alimentary Pharmacology & Therapeutics;2024-05-30

4. Editorial: ARFI‐based techniques are better than VCTE for diagnosing advanced fibrosis in severe obesity—Authors' reply;Alimentary Pharmacology & Therapeutics;2024-05-25

5. Assessing the Utility of Acoustic Radiation Force Impulse in the Evaluation of Non-Alcoholic Fatty Liver Disease with Severe Obesity or Steatosis;Diagnostics;2024-05-22